[1]
Kolomoets, O.S., Voskoboynik О.Y., Nosulenko, I.S., Krivoshey, O.V., Avramenko, A.I., Berest, G.G. and Kovalenko, S.I. 2017. 3’-R-Spiro[cycloalkyl-1(2), (hetaryl-3(4), 6’-[1,2,4]triazino[2,3-c]quinazoline]-2’(7’H)-2-оnes as a perspective class of compounds with actoprotective activity. Zaporozhye Medical Journal. 19, 2 (Mar. 2017). DOI:https://doi.org/10.14739/2310-1210.2017.2.95748.